Literature DB >> 2414617

[Perioperative staging and the Münster TNM classification in ampullary and pancreatic cancer].

M Clemens, J Meyer, U Sulkowski, W Sasse, H Bünte.   

Abstract

From 1974 to 1982 607 patients with diseases of the pancreas were treated at the Surgical University Clinic of Münster/West Germany. 256 of those suffered from pancreatic and 42 from ampullary cancer. All patients were grouped according to a TNM-System for pancreatic cancer developed for that particular purpose. Of the curative resections performed (n = 73) with a resection rate of 78.6% for ampullary and 15.6% for pancreatic cancer, a distinct preponderance of early stages (T1N0M0/T2N0M0 greater than 60%) was noticed for the first, of late stages for the latter (T1N0M0/T2N0M0 = 25%). The frequencies of distant metastases for all operations also differed significantly, being 9.5% respectively 43.4% at the time of operation (p less than 0.05). At the low mean survival time for palliative operations an mean survival time of 40.3 months for the Whipple operation was evaluated, of 28.0 months for total pancreatectomy. At the stage T1N0M0/T2N0M0 the mean survival time was greater than 63 months.

Entities:  

Mesh:

Year:  1985        PMID: 2414617     DOI: 10.1007/bf01261144

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  16 in total

1.  Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas.

Authors:  A S Hermreck; C Y Thomas; S R Friesen
Journal:  Am J Surg       Date:  1974-06       Impact factor: 2.565

2.  Clinical, pathologic, and therapeutic aspects of carcinoma of the pancreas.

Authors:  D W Collure; G P Burns; W G Schenk
Journal:  Am J Surg       Date:  1974-11       Impact factor: 2.565

3.  [Extended resection of pancreatic and periampullar carcinoma: regional, total and partial duodenopancreatectomy (author's transl)].

Authors:  F P Gall; P Hermanek; C Gebhardt; H Meier
Journal:  Leber Magen Darm       Date:  1981-08

4.  Needle biopsy diagnosis of pancreatic cancer.

Authors:  R M Beazley
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

5.  [Morphologic criteria of the growth behavior of pancreatic cancers. Experimental and clinico-pathologic studies].

Authors:  G Klöppel; G Lingenthal; R Klapdor; H F Kern; K Rückert; M von Bülow
Journal:  Dtsch Med Wochenschr       Date:  1984-05-04       Impact factor: 0.628

6.  Staging of cancer of the pancreas. Cancer of the Pancreas Task Force.

Authors: 
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

7.  Factors influencing survival after total pancreatectomy in patients with pancreatic cancer.

Authors:  A Andrén-Sandberg; I Ihse
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

8.  Significance of carcinoembryonic antigen levels and cytology of pure pancreatic juice in diagnosis of pancreatic cancer.

Authors:  M Tatsuta; H Yamamura; R Yamamoto; Y Okano; T Morii; S Okuda; H Tamura
Journal:  Cancer       Date:  1983-11-15       Impact factor: 6.860

9.  Cancer of the head of the pancreas and choledochoduodenal junction: a clinical study of 88 Whipple resections.

Authors:  S Björck; J O Svensson; S Macpherson; Y Edlund
Journal:  Acta Chir Scand       Date:  1981

10.  Factors influencing the late results of operation for carcinoma of the pancreas.

Authors:  T Sato; Y Saitoh; N Noto; S Matsuno
Journal:  Am J Surg       Date:  1978-11       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.